Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 3Completed 2

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Osteoporotic Fractures 1Osteoporosis 1Musculoskeletal Pain 1Arthralgia 1

Interventions

Cyclophosphamide 89Capecitabine 88Trastuzumab 81Docetaxel 81Paclitaxel 65Epirubicin 57pyrotinib 55Tamoxifen 54Letrozole 53Fulvestrant 49Vinorelbine 43Carboplatin 43Doxorubicin 41Radiotherapy 33Anastrozole 32exemestane 31Neoadjuvant Therapy 29palbociclib 27Drug Therapy 27Fluorouracil 24Bevacizumab 24pertuzumab 23Cisplatin 23eribulin 22Exercise 21130-nm albumin-bound paclitaxel 21Goserelin 20Gemcitabine 20Chemotherapy, Adjuvant 19Albumin-Bound Paclitaxel 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Diphosphonates × Breast × Clear all
NCT05680194 2023-01-11

EEBC

Peking Union Medical College Hospital

Unknown
1,000 enrolled
Breast

Breast Neoplasms

NCT03811509 2019-01-28

B-ABLE

Parc de Salut Mar

Phase 4 Unknown
1,000 enrolled
Breast

Breast Neoplasms, Osteoporosis, Arthralgia, Osteoporotic Fractures, Musculoskeletal Pain

NCT03543072 2018-06-20

A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Postmenopausal Breast Cancer Patients

Sun Yat-sen University

Unknown
2,000 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡